Bacterial flagellin stimulates Toll-like receptor 5-dependent defense against vancomycin-resistant Enterococcus infection
- PMID: 20064069
- PMCID: PMC2811237
- DOI: 10.1086/650203
Bacterial flagellin stimulates Toll-like receptor 5-dependent defense against vancomycin-resistant Enterococcus infection
Erratum in
- J Infect Dis. 2010 Apr 15;201(8):1278
Abstract
Treatment of vancomycin-resistant Enterococcus (VRE) infections is limited by the paucity of effective antibiotics. Administration of broad-spectrum antibiotics promotes VRE colonization by down-regulating homeostatic innate immune defenses. Intestinal epithelial cells and Paneth cells express antimicrobial factors on direct or indirect stimulation of the Toll-like receptor (TLR)-myeloid differentiation factor 88-mediated pathway by microbe-derived molecules. Here, we demonstrate that the TLR5 agonist flagellin restores antibiotic-impaired innate immune defenses and restricts colonization with VRE. Flagellin stimulates the expression of RegIIIgamma, a secreted C-type lectin that kills gram-positive bacteria, including VRE. Systemic administration of flagellin induces RegIIIgamma expression in intestinal epithelial cells and Paneth cells along the entire length of the small intestine. Induction of RegIIIgamma requires TLR5 expression in hematopoietic cells and is dependent on interleukin 22 expression. Systemic administration of flagellin to antibiotic-treated mice dramatically reduces VRE colonization. By enhancing mucosal resistance to multidrug-resistant organisms, flagellin administration may provide a clinically useful approach to prevent infections in patients treated with broad-spectrum antibiotics.
Figures






Similar articles
-
Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits.Nature. 2008 Oct 9;455(7214):804-7. doi: 10.1038/nature07250. Epub 2008 Aug 24. Nature. 2008. PMID: 18724361 Free PMC article.
-
Interleukin 23 production by intestinal CD103(+)CD11b(+) dendritic cells in response to bacterial flagellin enhances mucosal innate immune defense.Immunity. 2012 Feb 24;36(2):276-87. doi: 10.1016/j.immuni.2011.12.011. Epub 2012 Feb 2. Immunity. 2012. PMID: 22306017 Free PMC article.
-
TLR-7 activation enhances IL-22-mediated colonization resistance against vancomycin-resistant enterococcus.Sci Transl Med. 2016 Feb 24;8(327):327ra25. doi: 10.1126/scitranslmed.aad6663. Sci Transl Med. 2016. PMID: 26912904 Free PMC article.
-
Treatment options for vancomycin-resistant enterococcal infections.Drugs. 2002;62(3):425-41. doi: 10.2165/00003495-200262030-00002. Drugs. 2002. PMID: 11827558 Review.
-
Compartmentalized Antimicrobial Defenses in Response to Flagellin.Trends Microbiol. 2018 May;26(5):423-435. doi: 10.1016/j.tim.2017.10.008. Epub 2017 Nov 22. Trends Microbiol. 2018. PMID: 29173868 Review.
Cited by
-
Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis.Infect Immun. 2012 Jan;80(1):62-73. doi: 10.1128/IAI.05496-11. Epub 2011 Oct 17. Infect Immun. 2012. PMID: 22006564 Free PMC article.
-
Role of TLR5 in the Translocation and Dissemination of Commensal Bacteria in the Intestine after Traumatic Hemorrhagic Shock.J Immunol Res. 2021 Nov 19;2021:6417658. doi: 10.1155/2021/6417658. eCollection 2021. J Immunol Res. 2021. PMID: 34840990 Free PMC article.
-
Control of epithelial cell function by interleukin-22-producing RORγt+ innate lymphoid cells.Immunology. 2011 Apr;132(4):453-65. doi: 10.1111/j.1365-2567.2011.03410.x. Immunology. 2011. PMID: 21391996 Free PMC article. Review.
-
The IL-20 subfamily of cytokines--from host defence to tissue homeostasis.Nat Rev Immunol. 2014 Dec;14(12):783-95. doi: 10.1038/nri3766. Nat Rev Immunol. 2014. PMID: 25421700 Review.
-
Triggering Toll-Like Receptor 5 Signaling During Pneumococcal Superinfection Prevents the Selection of Antibiotic Resistance.J Infect Dis. 2024 Nov 15;230(5):e1126-e1135. doi: 10.1093/infdis/jiae239. J Infect Dis. 2024. PMID: 38716762 Free PMC article.
References
-
- Centers for Disease Control Nosocomial enterococci resistant to vancomycin--United States, 1989–1993. MMWR. 1993;42:597–9. - PubMed
-
- Hidron A, Edwards J, Patel J, et al. NHSN Annual Update: Antimicrobial□Resistant Pathogens Associated With Healthcare□Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect Control Hosp Epidemiol. 2008;29:996–1011. - PubMed
-
- Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis. 2006;42(Suppl 2):S82–9. - PubMed
-
- Fridkin SK, Edwards JR, Courval JM, et al. The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units. Ann Intern Med. 2001;135:175–83. - PubMed